Structure Therapeutics (GPCR) Return on Capital Employed (2023 - 2026)
Quarterly Return on Capital Employed rose 168.0% to 4.2% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 4.2% through Mar 2026, up 168.0% year-over-year, with the annual reading at 2.5% for FY2025, 141.0% up from the prior year.
Structure Therapeutics' Return on Capital Employed history spans 4 years, with the latest figure at 4.2% for Q1 2026.
- Return on Capital Employed came in at 4.2% for Q1 2026, down from 2.58% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 2.58% in Q4 2025 to a low of 41.78% in Q3 2023.
- The 4-year median for Return on Capital Employed is 15.68% (2024), against an average of 18.69%.
- Year-over-year, Return on Capital Employed surged 2877bps in 2024 and then soared 33bps in 2025.
- Structure Therapeutics' Return on Capital Employed stood at 31.68% in 2023, then soared by 91bps to 2.91% in 2024, then rose by 11bps to 2.58% in 2025, then tumbled by -63bps to 4.2% in 2026.
- Per Business Quant, the three most recent readings for GPCR's Return on Capital Employed are 4.2% (Q1 2026), 2.58% (Q4 2025), and 15.0% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 450.31% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 51.73% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -107.40% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 21.10% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 10.19% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 20.34% |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | -4.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.20% |
| Dec 31, 2025 | -2.58% |
| Sep 30, 2025 | -15.00% |
| Jun 30, 2025 | -10.85% |
| Mar 31, 2025 | -5.89% |
| Dec 31, 2024 | -2.91% |
| Sep 30, 2024 | -15.68% |
| Jun 30, 2024 | -18.02% |
| Mar 31, 2024 | -25.81% |
| Dec 31, 2023 | -31.68% |
| Sep 30, 2023 | -41.78% |
| Jun 30, 2023 | -31.91% |
| Mar 31, 2023 | -36.67% |